article thumbnail

Misjustice benefits pharma

World of DTC Marketing

Doctors, 99% of whom were acting in good faith, determined the total volume of prescription opioids that pharmacies ordered from defendants and dispensed pursuant to those prescriptions,” Faber wrote in his opinion. These were doctors whose only goal was to make money. Once again money rules.

Pharma 238
article thumbnail

Is DTC effective?

World of DTC Marketing

Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? Today it’s a multichannel approach.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. By 2020, that percentage plummeted to just 8%. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S. Symphony Health Solutions, practitioner insight’s data, 2022.

article thumbnail

DTC Marketers job just got harder

World of DTC Marketing

SUMMARY: Both emergency room visits and doctors’ visits are down by about half because people are putting off treatment for medical emergencies due to fears of contracting COVID-19. How is pharma going to get patients back into to ask their doctor about branded medications? Is telehealth a scam? Of that, $4.5

Marketing 155
article thumbnail

DTC forecasts are not really that reliable

World of DTC Marketing

SUMMARY: According to eMarketer, “in 2020, spending on digital advertising in the healthcare and pharma industry will grow by 14.2% While 75% agreed that being informed about pharma treatment options could save lives, more than 30% said they didn’t know enough information before they talked to their doctors. to reach $9.53

Doctors 227
article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

Big Pharma’s reputation has been down in the dumps for years, after a series of scandals involving Medicare fraud, improper payments to doctors, and poorly tested drugs that damaged health. By the look of 2020’s results, he’s on the right track—and his compensation shows it. For writing that 2020 success story, CEO Albert Bourla, Ph.D.,

Pharma 186
article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

million compensation package in 2020, a slight increase from his $19.6 Pfizer CEO Bourla’s Pay Climbed 17% to $21 Million in 2020 and Gilead Sciences CEO Daniel O’Day earned a $19 million take home. Patients are becoming healthcare consumers, but their doctor is still the gatekeeper of health recommendations.